低密度脂蛋白受體相關蛋白5(LRP5)重組蛋白

Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5)

HBM; BMND1; EVR1; EVR4; LR3; LRP7; OPPG; OPS; OPTA1; VBCH2; Osteoporosis Pseudoglioma Syndrome; Exudative Vitreoretinopathy 1

[ PROPERTIES ]

Source: Prokaryotic expression. Host: E. coli

Residues: Ile102~Cys336

Tags: N-terminal His-Tag

Purity: >95%

Traits: Freeze-dried powder

Buffer formulation: 100mM NaHCO3, 500mM NaCl, pH8.3, containing 1mM

EDTA, 1mM DTT, 0.01% sarcosyl, 5%Trehalose and Proclin300. Original Concentration: 200ug/mL

Applications: SDS-PAGE; WB; ELISA; IP; CoIP; Purification; Amine Reactive

Labeling. (May be suitable for use in other assays to be determined by the end user.)

Predicted isoelectric point: 5.4

Predicted Molecular Mass: 30.3kDa

Accurate Molecular Mass: 30kDa as determined by SDS-PAGE reducing conditions.

?[ USAGE ]

Reconstitute in 100mM NaHCO3, 500mM NaCl (pH8.3) to a concentration of0.1-1.0 mg/mL. Do not vortex.?

[ STORAGE AND STABILITY ]

Storage: Avoid repeated freeze/thaw cycles. Store at 2-8

oC for one month. Aliquot and store at -80

oC for 12 months.?

Stability Test: The thermal stability is described by the loss rate. The loss ratewas determined by accelerated thermal degradation test, that is, incubate theprotein at 37oC for 48h, and no obvious degradation and precipitation wereobserved.The loss rate is less than 5% within the expiration date under

appropriate storage condition.

[ SEQUENCE ]

特別提示：本公司的所有產(chǎn)品僅可用于科研實驗，嚴禁用于臨床醫(yī)療及其他非科研用途！?